$BELLUS Health (BLU.US)$ announced a positive interim analy...
$BELLUS Health(BLU.US$ announced a positive interim analysis of the Phase 2B SOOTHE trial for Treating refractory chronic cough, which met the threshold for high probability of clinical efficacy.
The SOOTHE Phase 2B trial is expected to provide top-line results in the fourth quarter
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
